Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Albendazole Sulfoxide
47%
Pharmacokinetics
47%
Intravenous Administration
31%
Sheep
30%
Intramuscular Administration
27%
Albendazole
27%
Cmax
25%
Leishmania Infantum
24%
Oral Administration
23%
Pharmacokinetic Parameters
23%
Plasma Concentration
23%
Propafenone
21%
Thiamphenicol
21%
Bupivacaine
21%
Doramectin
21%
High-performance Liquid Chromatography
19%
Meglumine Antimoniate
18%
Pregnant Ewes
17%
Leishmaniasis
16%
Disposition Kinetics
16%
Developmental Toxicity
16%
Ivermectin
16%
Diphenylhydantoin
16%
Placental Transfer
16%
Rat Embryo
16%
Blood Samples
15%
Fetus
15%
Racemic
14%
Canine Leishmaniosis
14%
Peak Plasma Concentration
14%
Plasma Disposition
14%
Liposome-encapsulated
14%
Leishmania
13%
Subcutaneous Administration
13%
Lamb
13%
Elimination Half-life
13%
Antimony
12%
Mean Residence Time
11%
Promastigote
11%
Age of Infection
11%
Liver
11%
Anthelmintic
10%
Tylosin
10%
Pregnant Rats
10%
Ricobendazole
10%
Epidural Administration
10%
Moxidectin
10%
Sustained Release
10%
Fecal Elimination
10%
Lipid Emulsion
10%
Veterinary Science and Veterinary Medicine
Blood Plasma
100%
Dog
79%
Albendazole
48%
Leishmania
34%
Infectious Disease
25%
Rat
24%
Intramuscular Drug Administration
20%
Intramuscular Injection
20%
Meglumine
18%
Ivermectin
16%
Doramectin
16%
Bupivacaine
16%
Leishmaniasis
15%
Canine Leishmaniasis
15%
Muscle
12%
Blood Sample
11%
Mast Cell
10%
Moxidectin
10%
Epidural Drug Administration
10%
Mouse
10%
Metabolic Pathway
8%
Beagle Dog
8%
Leporidae
8%
Bioavailability
7%
Asymptomatic Dogs
7%
Endemic Disease
5%
Canis
5%
Ossification
5%
Small Mammal
5%
Placenta
5%
Hounds
5%
Fibrinogen
5%
Dermatitis
5%
Propofol
5%
Taenia multiceps
5%
Serology
5%
Heifer
5%
Dairy Cows
5%
Ulna
5%
Prevalence
5%
Cow
5%
Immunoglobulin G
5%
Carpometacarpus
5%
Tarsometatarsus
5%
Tibiotarsus
5%
Lamb
5%
Obstetrical Anesthesia
5%
Pharmacology, Toxicology and Pharmaceutical Science
Albendazole Sulfoxide
40%
Pharmacokinetics
30%
Elimination
30%
Netobimin
26%
Intramuscular Injection
25%
Pharmacokinetic Parameter
19%
High Performance Liquid Chromatography
18%
Leporidae
17%
Oral Administration
17%
Albendazole
16%
Doramectin
16%
Bupivacaine
16%
Thiamphenicol
16%
Propafenone
16%
Phenytoin
16%
Anthelmintic Agent
13%
Benzimidazole
13%
Lamb
12%
Subcutaneous Injection
12%
Liposome
12%
Moxidectin
10%
Gentamicin
10%
Sustained Release
10%
Developmental Toxicity
10%
Intramuscular Route
8%
Volume of Distribution
7%
Beagle
7%
5 (4 Hydroxyphenyl) 5 Phenylhydantoin
6%
Pharmacokinetic Modeling
5%
Hemostatic Agent
5%
Enrofloxacin
5%
Salmonella Enterica Serovar Typhimurium
5%
Vinblastine
5%
Multidrug Resistance
5%
Lipid Emulsion
5%
P-Glycoprotein
5%
Mutagenicity
5%
Chick
5%
Atenolol
5%
Abamectin
5%
Propofol
5%
Blood Clotting Disorder
5%
Ivermectin
5%
Pharmacodynamic Modeling
5%
Tobramycin
5%
Acenocoumarol
5%
Etomidate
5%
Rumen Microorganism
5%
Congenital Malformation
5%
Experimental Leishmaniasis
5%
